Baxano is also in the process of developing the iO-Tome precision facetectomy instrument.
TranS1 executives said the acquisition will help the company grow its minimally invasive spine procedure market presence.
More Articles on Devices:
14 News Updates for Spine & Orthopedic Device Companies
Orthopedic Product Sales Exceed $43B in 2012
FDA Grants Priority Review, Biologics License Application to Metabolic Disease
